Stockscreener 앱 받기
22.28
4.36%
0.93
시간 외 거래:
22.28
전일 마감가:
$21.35
열려 있는:
$21.35
하루 거래량:
829.32K
Relative Volume:
1.65
시가총액:
$646.30M
수익:
$219.79M
순이익/손실:
$-57.47M
주가수익비율:
-10.36
EPS:
-2.15
순현금흐름:
$-19.25M
1주 성능:
+12.64%
1개월 성능:
+38.64%
6개월 성능:
-11.87%
1년 성능:
-24.32%
1일 변동 폭
$21.24
$22.35
1주일 범위
$19.59
$22.35
52주 변동 폭
$14.59
$35.84
Castle Biosciences Inc Stock (CSTL) Company Profile
명칭
Castle Biosciences Inc
전화
866-788-9007
주소
505 S FRIENDSWOOD DRIVE, FRIENDSWOOD, TX
CSTL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CSTL
Castle Biosciences Inc
|
22.28 | 619.33M | 219.79M | -57.47M | -19.25M | -2.15 |
|
TMO
Thermo Fisher Scientific Inc
|
488.12 | 184.46B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
205.00 | 147.69B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
640.86 | 51.34B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
118.69 | 33.60B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
188.80 | 31.92B | 15.70B | 1.24B | 2.01B | 6.91 |
Castle Biosciences Inc Stock (CSTL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-12-14 | 개시 | Guggenheim | Buy |
| 2023-01-05 | 개시 | Scotiabank | Sector Outperform |
| 2022-01-07 | 개시 | Stephens | Overweight |
| 2021-04-30 | 개시 | Lake Street | Buy |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2019-12-27 | 재확인 | Canaccord Genuity | Buy |
| 2019-08-19 | 개시 | BTIG Research | Buy |
| 2019-08-19 | 개시 | Canaccord Genuity | Buy |
| 2019-08-19 | 개시 | Robert W. Baird | Outperform |
| 2019-08-19 | 개시 | SVB Leerink | Outperform |
모두보기
Castle Biosciences Inc 주식(CSTL)의 최신 뉴스
Can a trend reversal in Castle Biosciences Inc. lead to recoveryEarnings Recap Report & Daily Growth Stock Tips - Newser
Castle Biosciences Inc. stock outlook for YEARTrend Reversal & Low Risk Entry Point Guides - Newser
News impact scoring models applied to Castle Biosciences Inc.2025 AllTime Highs & Risk Controlled Stock Alerts - Newser
Trend analysis for Castle Biosciences Inc. this weekWeekly Stock Analysis & Short-Term Trading Alerts - Newser
Will Castle Biosciences Inc. see short term momentumTrade Exit Report & Consistent Profit Alerts - Newser
What data driven models say about Castle Biosciences Inc.’s futureDividend Hike & Verified Trade Idea Suggestions - Newser
What indicators show strength in Castle Biosciences Inc.Portfolio Risk Summary & Accurate Trade Setup Notifications - Newser
Using data filters to optimize entry into Castle Biosciences Inc.July 2025 Market Mood & High Yield Stock Recommendations - Newser
Heatmap Data Shows High Activity in Castle Biosciences Inc. Sector getLinesFromResByArray error: size == 0 - kangso.co.kr
Tools to assess Castle Biosciences Inc.’s risk profileWeekly Investment Summary & AI Optimized Trade Strategies - Newser
Castle Biosciences Inc. stock prediction for this weekEntry Point & Free Technical Confirmation Trade Alerts - Newser
Visualizing Castle Biosciences Inc. stock with heatmapsWeekly Trading Summary & Weekly High Potential Stock Alerts - Newser
Real time social sentiment graph for Castle Biosciences Inc.2025 Key Highlights & Smart Money Movement Alerts - Newser
Automated trading signals detected on Castle Biosciences Inc.July 2025 Sentiment & Daily Volume Surge Trade Alerts - Newser
What candlestick patterns are forming on Castle Biosciences Inc.Portfolio Profit Report & Daily Oversold Bounce Ideas - Newser
Reversal indicators forming on Castle Biosciences Inc. stock2025 EndofYear Setup & Safe Capital Allocation Plans - Newser
New Studies Expand Clinical Role of DecisionDx-SCC in High-Risk cSCC - Dermatology Times
Castle Biosciences' DecisionDx-SCC Outperforms Current Staging Systems in Predicting Risk for High-Risk Cutaneous Squamous Cell Carcinoma - Quiver Quantitative
Risk vs reward if holding onto Castle Biosciences Inc.Quarterly Profit Report & Pattern Based Trade Signal System - Newser
New Evidence Published Supporting Use of DecisionDx®-SCC - GlobeNewswire
95.3% Survival Rate: Castle Bio's Revolutionary Skin Cancer Test Transforms Treatment Decision-Making - Stock Titan
Institutional scanner results for Castle Biosciences Inc.2025 Pullback Review & Short-Term Trading Opportunity Alerts - Newser
Chart overlay techniques for tracking Castle Biosciences Inc.Jobs Report & Free Fast Entry Momentum Trade Alerts - Newser
What Castle Biosciences, Inc.'s (NASDAQ:CSTL) 30% Share Price Gain Is Not Telling You - simplywall.st
Ideas Watch: Is Castle Biosciences Inc. in a bullish channelTrade Signal Summary & Short-Term Trading Opportunity Alerts - theviewers.co.kr
Smart tools for monitoring Castle Biosciences Inc.’s price actionQuarterly Portfolio Summary & Community Consensus Trade Alerts - Newser
Castle Biosciences to Present at Three Investor Conferences in September 2025 - AInvest
Is Castle Biosciences Inc. on track to beat earnings2025 Price Momentum & Daily Stock Trend Watchlist - theviewers.co.kr
Using RSI to spot recovery in Castle Biosciences Inc.Market Risk Summary & Growth Focused Investment Plans - Newser
Castle Biosciences shares rise 1.80% intraday after announcing participation in Baird’s 2025 Global Healthcare Conference. - AInvest
Castle Biosciences shares fall 2.93% premarket after announcing participation in Baird’s 2025 Global Healthcare Conference. - AInvest
Castle Biosciences to Participate in Upcoming Investor Conferences - GlobeNewswire
Diagnostic Testing Innovator Castle Biosciences Sets Three Major Healthcare Conference Appearances in September - Stock Titan
How hedge fund analytics apply to Castle Biosciences Inc. stockTrade Risk Assessment & Proven Capital Preservation Methods - Newser
Published on: 2025-08-19 16:13:25 - Newser
Published on: 2025-08-17 16:08:16 - Newser
Is Castle Biosciences Inc.’s ROE strong enoughWeekly Gains Report & Free Weekly Watchlist of Top Performers - newsyoung.net
Published on: 2025-08-16 21:19:23 - sundaytimes.kr
Why Castle Biosciences Inc. stock attracts strong analyst attentionJuly 2025 Retail & Target Return Focused Stock Picks - mustnews.co.kr
Is Castle Biosciences Inc. Stock Overbought or Oversold RSI Indicator AnalysisEarnings Miss & Low Drawdown Trading Techniques - Newser
Predictive Oncology Q2 EPS 22c, down from 53c YoY, revenue at $2,682, down from $67,255 YoY. - AInvest
Tools to monitor Castle Biosciences Inc. recovery probability2025 Market Outlook & Smart Money Movement Tracker - Newser
Is Castle Biosciences Inc. in a consolidation phaseMarket Sentiment Summary & Free Reliable Trade Execution Plans - 더경남뉴스
What is the PEG ratio of Castle Biosciences Inc.2025 Price Action Summary & Growth Focused Investment Plans - classian.co.kr
Will Castle Biosciences Inc. outperform tech stocksMax Yield Daily Selections - mustnews.co.kr
Castle Biosciences Updates Bylaws for Improved Governance - TipRanks
CSTL SEC FilingsCastle Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan
Price Clustering Detected in Castle Biosciences Inc. StockExit Ready Momentum Stock Watchlist Expanded - beatles.ru
Castle Biosciences Inc (CSTL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.51%
0.31%
자본화:
|
볼륨(24시간):